logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Repros Jumps on Positive Drug Trials

By  +Follow September 17, 2013 8:01AM
Share:
Tickers Mentioned:

Shares in Texas pharma Repros Therapeutics, Inc. (RPRX) gapped up over 30 percent in early morning trading before settling into gains of just over 10 percent on heavy volume as the day wore on. The spike, driven by positive topline results from the most recent study on its drug Androxal® reported after close on Monday, pushed Repros stock to a new 52-week high.

Positive results for Androxal

Androxal is being developed for men of reproductive age with low testosterone due to secondary hypogonadism, which is also associated with obesity and could be among the most common causes of low testosterone. Repros reported that Andorxal met both co-primary endpoints in its second pivotal study, with 81 percent of subjects using the drug experiencing normalized testosterone and no 24-hour average testosterone levels outside of normal ranges. Androxal, which is in a class similar to Sanofi’s (SNY) Clomid®, could receive a strong share of the testosterone replacement therapy (TRT) market because it could also help preserve male fertility while being administered orally, making it significantly more convenient than testosterone replacement injections.  

Possible Sale

Brean Capital initiated coverage of Repros in July of this year, calling it a buy and setting a price target of $32. At the time, analyst Jonathan Aschoff said “Its lead compound Androxal is being evaluated in a Phase 3 program for secondary hypogonadism with results in 4Q13 and 2Q14, which in our view would be key investment catalysts, and we project Androxal launch in mid-2015.” Now, Brean is citing these positive results as a reason for optimism, as well as reports that management may have interest in selling the company. Brean estimated the sell-price potentially reaching $40 a share, in the event that the sale goes down.

In addition to Andorxal, Repros currently has female reproductive drug Proellex® in the pipeline, intended for use in uterine fibroids and endometriosis. “The vaginal formulation of Proellex (Proellex-V) will enter Phase 2b in 2H13 for uterine fibroids with an NDA submission expected in 2016. All compounds are protected by U.S. patents," said Aschoff in July.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com and Connect With Your Favorite Financial Experts FOR FREE! Members of Equities.com gain access to our leading financial news and content, active social investment community, proprietary research tools including the 2014 Small-Cap Stars, E.V.A. reports and more.

Results for RPRX
Alvan Duckworth
2 Mar 15 09:27:07
$RPRX out 9.00
BULLDOG INVESTOR
1 Mar 15 18:30:45
Watch list for MON $ZIOP $ADHD $HART $AT $EYES $EXEL $ARCP $RPRX $NUGT $IAG $NG $OAS $BAS
Breaking News Now
1 Mar 15 17:36:01
$RPRX: Share Price of Repros Therapeutics Inc. Drops by -0.65%: http://t.co/vBrhYZjVDU
dfgdf dgffdg
1 Mar 15 14:09:11
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
Md. Ruhul Amin
1 Mar 15 14:08:26
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
chraa
1 Mar 15 14:07:59
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
Farzad Rahimi
1 Mar 15 14:07:17
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
Jowkster
1 Mar 15 14:06:36
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
Gana Dolares Ya!!!
1 Mar 15 14:06:07
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
Tyler Ikari
1 Mar 15 14:04:58
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
kraiser
1 Mar 15 14:04:00
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
Wat The Actual Facts
1 Mar 15 14:02:57
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
client balle
1 Mar 15 14:02:32
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
ipayz
1 Mar 15 14:02:12
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
Jose Luis R
1 Mar 15 14:01:32
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
pawit akkarachokkul
1 Mar 15 14:00:22
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
dquangdat1
1 Mar 15 13:58:45
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
Jhon White
1 Mar 15 13:57:48
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
Makaro
1 Mar 15 13:57:35
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
- Tweetnya Aditya -
1 Mar 15 13:57:18
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
Myriam Loney
1 Mar 15 13:56:52
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
deli Johns
1 Mar 15 13:56:40
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
Lucky Lion
1 Mar 15 13:56:16
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
Penny Stock Secret
28 Feb 15 06:26:28
Yesterday We Made $89,000 In Just One Trade More Info Here http://t.co/NovWYe2RAx .. $ANAC $ACTV $RPRX
Stockaholics
27 Feb 15 22:39:58
Our Penny Stock Picks Gained Over 342% In 2 weeks! Get Our Next Alerts Early: http://t.co/iPnInrsUzz $ANAC $ACTV $RPRX
Stock Rocket
27 Feb 15 18:54:31
Our Penny Stock Picks Gained Over 342% In 2 weeks! Get Our Next Alerts Early: http://t.co/WWiSMpV7jj $ANAC $ACTV $RPRX
Stockaholics
27 Feb 15 12:38:57
Our Penny Stock Picks Gained Over 342% In 2 weeks! Get Our Next Alerts Early: http://t.co/iPnInrsUzz $ANAC $ACTV $RPRX
Stock Rocket
27 Feb 15 07:50:05
Our Penny Stock Picks Gained Over 342% In 2 weeks! Get Our Next Alerts Early: http://t.co/WWiSMpV7jj $ANAC $ACTV $RPRX
S Manian
27 Feb 15 07:24:44
@zerosum24 great call // $nsph or $rprx could be next ;)
S Manian
27 Feb 15 06:18:51
RT @stt2318: $RPRX long setup http://t.co/wc7ZDfLQLQ
S Manian
27 Feb 15 06:18:15
RT @VexTrades: $RPRX - http://t.co/4gkfluiKEP Long setup.
Brandon Hayward
27 Feb 15 06:17:36
$RPRX - http://t.co/4gkfluiKEP Long setup.
Jarrad Fiorito
27 Feb 15 05:51:08
RT @stt2318: $RPRX long setup http://t.co/wc7ZDfLQLQ
stt2318
27 Feb 15 05:10:56
$RPRX long setup http://t.co/wc7ZDfLQLQ
BioPharmaZ
27 Feb 15 04:50:53
RT @zerosum24: $RPRX downtrend line breakout could produce a powerful move here since that resistance dates back five months. http://t.co/d…
S Manian
27 Feb 15 02:44:58
RT @lakith_l: New post: Watchlist - 27th Feb http://t.co/wXVX0nTmaY #daytrading $ABT $BLUU $MCEP $POR $RPRX
S Manian
27 Feb 15 02:44:48
RT @zerosum24: $RPRX downtrend line breakout could produce a powerful move here since that resistance dates back five months. http://t.co/d…
Lakith L
26 Feb 15 22:46:56
New post: Watchlist - 27th Feb http://t.co/wXVX0nTmaY #daytrading $ABT $BLUU $MCEP $POR $RPRX
BULLDOG INVESTOR
26 Feb 15 22:19:53
RT @zerosum24: $RPRX downtrend line breakout could produce a powerful move here since that resistance dates back five months. http://t.co/d…
Gotham City Capital
26 Feb 15 22:00:29
RT @zerosum24: $RPRX downtrend line breakout could produce a powerful move here since that resistance dates back five months. http://t.co/d…
roberto pedone
26 Feb 15 21:40:27
$RPRX downtrend line breakout could produce a powerful move here since that resistance dates back five months. http://t.co/dkENdxhrz0
Stockaholics
26 Feb 15 16:56:52
$HIPPQ Closed up 275% Yesterday, As One Of The Best Penny Stocks of the Day! Big Update: http://t.co/KKZkbfPf1Q $ANAC $ACTV $RPRX
Alex Kim
26 Feb 15 13:42:45
@adamfeuerstein @Ken_Kulig $LPCN? 2.5B TRT market with no orals. $RPRX Podolski will probably fuck up NDA and approval like usual.
Stockaholics
26 Feb 15 12:03:58
$HIPPQ Closed up 275% Yesterday, As One Of The Best Penny Stocks of the Day! Big Update: http://t.co/KKZkbfPf1Q $ANAC $ACTV $RPRX
browns
26 Feb 15 11:18:43
$RPRX getting a push
scotty g
26 Feb 15 11:05:18
RT @DrSManian: $snta $rprx $nsph on the runway now
BioPharmaZ
26 Feb 15 11:02:26
@RaginCajun $RPRX just mentioned Robert Perdone article http://t.co/3knQWsLmqD $CLDX. $CEMP. $CTIC
S Manian
26 Feb 15 10:37:56
$snta $rprx $nsph on the runway now
S Manian
26 Feb 15 10:35:07
RT @RaginCajun: $RPRX moving here
S Manian
26 Feb 15 10:35:05
RT @703trader: $RPRX wound tight
				
				
By  +Follow September 17, 2013 8:01AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.